ECM
AGL icon

Engle Capital Management’s Agilon Health AGL Stock Holding History

Engle Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,680
Closed -$4.74M – 28
2023
Q3 		$4.74M Sell
10,680
-1,120
-9% -$506K 1.72% 21
2023
Q2 		$5.12M Sell
11,800
-4,896
-29% -$2.75M 1.58% 24
2023
Q1 		$9.91M Buy
16,696
+5,456
+49% +$3.06M 3.25% 16
2022
Q4 		$4.54M Sell
11,240
-8,200
-42% -$3.85M 2.04% 16
2022
Q3 		$11.4M Buy
+19,440
New +$11.6M 3.34% 12

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Engle Capital Management's AGL Position: Q4 2023 in Review

Engle Capital Management sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 10,680 shares — an estimated $4.74M sold.

Engle Capital Management first reported a position in AGL in Q3 2022 and held it in 5 quarters. The position peaked at $11.4M in Q3 2022. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

  • Engle Capital Management reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
  • Engle Capital Management sold 10,680 Agilon Health shares in Q4 2023, an estimated $4.74M.
  • Engle Capital Management first reported a position in Agilon Health in Q3 2022 and held it in 5 quarters.
  • Engle Capital Management's Agilon Health position peaked at $11.4M in Q3 2022.
  • 193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Engle Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.